EMF-Link [ EMF-Link Home | Online Store | Comments | Up One Level ]

EMF RAPID:
Status of Health Effects Research Through Fiscal Year 1995.
Project Summaries, Experimental Designs, and Results.

Last modified on: Thursday, March 11, 1999 11:08:52
Copyright © 1994-2008, Information Ventures, Inc.

TITLE: Environmental Risk Factors and Breast Cancer in the NHS
Principal
Investigator
David Hunter, Sc.D., M.P.H. Channing Laboratory
Health
Relevance
Cancer
Research
Categories
Studies with People Epidemiology Research Dietary Factors
FY95 Funds R01CA/ES62984 $ 303,572 Start Date 9/30/93 End Date 9/29/96
Rationale and
Summary
Research into potential environmental causes of breast cancer has been stimulated by reports of an increased incidence of the disease over time both in developed and developing countries. To date it has been extremely difficult to separate these temporal trends from issues related to better diagnostic techniques or more judicious, or at least more frequent, use of screening techniques. More recently concern has been expressed in regard to specific environmental agents because of regional differences in breast cancer incidence and mortality rates.

This is an epidemiological project designed to address a number of hypotheses related to environmental risks for breast cancer:

Specific Aim 1. Are DDE (bis[4-dichlorophenyl]-1,1-dichloroethane)/PCB (polychlorinated biphenyl compounds) levels related to breast cancer in a nested case-control study?

Specific Aim 2. Are regional differences in breast cancer rates explained by known breast cancer risk factors, or variations in diet or alcohol consumption?

Specific Aim 3. Does regular overnight use of an electric blanket increase risk of breast cancer?

Specific Aim 4. Are levels of 25-hydroxy vitamin D related to breast cancer in a nested case- control study?

Experimental
Design and
Exposure
Conditions
This study takes advantage of both the available data in an ongoing well-characterized prospective cohort of middle-aged women, as well as biological indicators of exposure to assess environmental risk factors for breast cancer in the Nurses’ Health Study. The Nurses’ Health Study was begun in 1976 with the establishment of a cohort of 120,700 women aged 30-55 and was principally designed to assess risk factors for breast cancer. Cohort members initially resided in 11 geographically dispersed states representing the Northeast (Massachusetts, Connecticut, New York, New Jersey, Pennsylvania, Maryland), Northcentral (Ohio, Michigan), the West (California) and the South (Texas, Florida); although the majority of participants still reside in the original 11 states, members of the cohort currently live in all 50 states. These women report on exposures and disease outcomes every two years and follow-up in the cohort has been maintained at a level of better than 90% through 1990.

To accomplish the specific aims we will utilize prospective data from the Nurses cohort, and perform nested case-control studies based in the cohort of 33,000 women from whom we obtained a blood sample in 1989-90. We will analyze levels of DDE and PCB’s among 430 women expected to develop breast cancer after giving us a blood sample and before June 1, 1996, and compare these with levels among 430 controls matched on year of birth and month of blood return. Similarly, we will analyze these specimens for 25-hydroxy vitamin D, the major circulating metabolite of vitamin D.

In 1992 we enquired about electric blanket us. Use of electric blankets is an important source of exposure to EMF and it has been implicated in breast cancer etiology in a previous case-control study. We will study this exposure prospectively. In four years of follow-up we expect 1,652 cases to occur which will give us ample power to examine this issue.

We will study regional variations in the incidence and mortality of breast cancer prospectively from the start of the study in 1976. We will examine the prevalence of specific risk factors, including screening behavior, in each region, and control for these risk factors to assess the extent to which they explain regional variations in incidence and mortality.

Quality
Assurance
Measures
An issue in any cohort study is the generalizability of the results. We have compared the age- adjusted breast cancer incidence in the Nurses’ Health Study with that reported from the NCI Surveillance, Epidemiology and End Results (SEER) Program, which is based on population registries for cancer incidence that cover approximately 10% of the US population. Overall, during 12 years of follow-up (1976-88) we observed 97% of the expected number of breast cancers, and the age-specific rates in the NHS were very similar to the SEER rates, suggesting (but not proving) that results from the NHS are likely to be generalizable.

DDE and PCB determinations: In year one, Mary Wolf of the Mt. Sinai Hospital, New York City, developed methods to analyze organochlorine pesticide residues in 0.5 ml samples of plasma rather than 1 ml samples. We then tested these procedures in a blinded quality control test. We submitted 25 blinded split specimens from 12 individuals under code to her laboratory for analysis. The results indicated excellent assay precision. For DDE the within-to-between variance ratio was 0.04, for total PCBs this was 0.02. The Spearman correlation between samples was 0.96 for DDE, 0.98 for PCBs. The mean coefficient of variation between specimens (s.d./mean) percent was 6.3 for DDE, 7.5 for PCB. For DDE the concentration was not significantly correlated with the CV percent (r = 0.07, p = 0.74). For PCB the mean was inversely correlated with CV percent (r = -0.54, p = 0.01), implied that the assay was less precise at lower PCB concentrations. Levels of DDE and PCBs were not significantly correlated (r = 0.10, p = 0.65).

Results and
Discussion
The relationship of DDE/PCB levels to breast cancer: We have sent Dr. Wolf 240 case-control specimens for the case-control study. So far, 120 of these specimens have been analyzed, and initial analysis of the blinded QC material indicates that the lab assay precision is being maintained.

Regional differences in breast cancer rates and known breast cancer risk factor: We are continuing our analyses of regional differences in breast cancer incidence in the Nurses’ Health Study. To date, we do not see clear, large differences in breast cancer incidence, although age-adjusted incidence is somewhat higher in California and lower in Texas than average incidence. Controlling for known breast cancer risk factors further attenuates these differences. Multi variate analysis is ongoing.

Regular use of electric blankets and breast cancer: We have completed our sub-study to analyze the reproducibility of the questions we asked prospectively on the Nurses’ Health Study Questionnaire on electric blanket and waterbed use. We mailed a much more detailed instrument to 500 cohort members, inquiring about lifetime patterns of electric blanket and waterbed use. We received questionnaires back from 421 women. Comparison between the detailed instrument and the original questionnaire suggests that concordance is high for a history of never or very infrequent electric blanket use, as well as a history of long duration and frequent electric blanket use, suggesting that we can discriminate these two extremes of exposure. For example, comparing the supplemental questionnaire with the 1992 Nurses’ Health Study Questionnaire information, and asking about electric blanket use between 1989 and 1991 categorized as 0 years or 3+ years, the Nurses’ Health Study Questionnaire information had sensitivity of 0.94, and specificity of 0.95 compared with the supplemental questionnaire.

Levels of 25-hydroxy vitamin D and breast cancer: We have continued to send specimens to Dr. Michael Holick, at Boston University, and vitamin D analyses are ongoing.

Findings are limited to the preparatory and validation studies. In year 3 we will start to test the main hypotheses.

Recent
Publications
None reported.

IVI Online Home Page EMF-Link Home Page Leave Us a Comment

Copyright (c) 1994-2008, Information Ventures, Inc.
Mail us at: Customer-Service@infoventures.com
http://infoventures.com